Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation

Transplant Proc. 1993 Feb;25(1 Pt 2):1234-6.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal / toxicity*
  • Biomarkers / blood
  • Bone Marrow Transplantation / adverse effects
  • Bone Marrow Transplantation / immunology*
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / therapy*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery
  • Mice
  • Mice, Inbred Strains
  • Myelodysplastic Syndromes / surgery
  • Pilot Projects
  • Survival Analysis
  • Transplantation, Homologous
  • Tumor Necrosis Factor-alpha / analysis
  • Tumor Necrosis Factor-alpha / immunology*

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • Biomarkers
  • Tumor Necrosis Factor-alpha